Celestica's AI Hardware Boom: Growth, Margins, And Market Mispricing

Celestica's HPS revenue mix rose to 42% in Q1 FY26, up 400 bps sequentially, signaling a continued shift from low-margin EMS toward higher-margin ODM. The mix shift is driving adjusted operating margin expansion and a stronger valuation case, with further upside tied to 1.6T and 3.2T CPO switch ramps in late 2026 and 2027. The article is constructive on CLS's margin trajectory and product-led growth outlook.

Analysis

The market is likely underappreciating how quickly the mix shift can re-rate the equity: ODM content typically changes the earnings algorithm from cyclical box-builder to semi-structural platform supplier, and that tends to compress perceived downside volatility while expanding multiple capacity. The second-order winner is the HPS ecosystem around optics, photonics, packaging, and advanced PCB/thermal vendors, because each step up in switch complexity increases bill-of-materials intensity and qualification stickiness. Competitively, this should pressure lower-tier EMS peers that lack design ownership; they may see worse pricing and lower attachment rates as customers migrate spend toward integrated, high-performance platforms.

The key risk is timing mismatch: the valuation case is already being pulled forward, while the next material product inflection appears to be a late-2026 to 2027 story. That creates a window where the stock can de-rate if investors conclude the margin step-up is “done” before the next wave ramps, especially if HPS order cadence normalizes or customer concentration rises. Any delay in CPO qualification, yield learning, or supply availability would matter disproportionately because the bull thesis depends on a clean bridge from mix gains to sustained operating leverage.

From a contrarian standpoint, the consensus may be extrapolating linear margin expansion from mix alone, when the bigger upside could come from pricing power on scarce technical capacity rather than product mix per se. If this is true, the earnings upside should be more durable than the market expects, but only if the company retains engineering control and avoids becoming a pass-through assembler with higher complexity but no economics. The market may also be missing that this transition can improve capital efficiency: higher-value content usually supports better ROIC even if revenue growth is only mid-teens, which can justify a multiple expansion before the next launch cycle.

The main reversal triggers are a slowdown in HPS end-demand, customer insourcing of strategic designs, or any evidence that newer programs cannibalize margin through faster-than-expected ramp costs. Watch the next 1-2 quarters for gross margin quality, not just revenue growth, because the setup is vulnerable if operating margin expansion comes from favorable mix rather than repeatable design wins. If management signals that late-2026/2027 products are already securing design slots, the current move likely remains under-owned; if not, the stock becomes a classic 'show-me' story.

Key Decisions for Investors

• Go long CLS on pullbacks over the next 2-6 weeks, targeting a 6-12 month hold; risk/reward is attractive if the market is still valuing it like an EMS name rather than a higher-multiple ODM/platform supplier.
• Consider a pair trade: long CLS / short a basket of lower-value-add EMS peers over 3-9 months; the trade benefits if the market continues to reward mix shift and technical content while commoditized peers face margin pressure.
• Use call spreads in CLS for the 6-12 month window instead of outright stock if you want exposure to re-rating without paying full delta for a story that may take quarters to prove.
• Trim or hedge if management commentary implies the margin step-up is mostly mix-driven and not repeatable; that would reduce the upside case from a multi-quarter rerate to a shorter-lived earnings beat.
• Watch for confirmation in the next two earnings prints: if operating margin expands again despite flatter revenue, add; if margins stall ahead of the 2026/2027 ramps, reduce exposure.